Entry |
|
Symbol |
MAP3K7, CSCF, FMD2, MEKK7, TAK1, TGF1a
|
Name |
(RefSeq) mitogen-activated protein kinase kinase kinase 7
|
KO |
|
Organism |
|
Pathway |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04621 | NOD-like receptor signaling pathway |
hsa04622 | RIG-I-like receptor signaling pathway |
hsa04660 | T cell receptor signaling pathway |
hsa05130 | Pathogenic Escherichia coli infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
|
Element |
N00151 | TNF-NFKB signaling pathway |
N00173 | KSHV K15 to TNF-NFKB signaling pathway |
N00186 | IL1-IL1R-p38 signaling pathway |
N00188 | IL1-IL1R-JNK signaling pathway |
N00265 | EBV LMP1 to NFKB signaling pathway |
N00435 | TLR1/2/4-NFKB signaling pathway |
N00438 | TLR2/4-MAPK signaling pathway |
N00441 | HIV gp120 to TNF-NFKB signaling pathway |
N00442 | HIV Nef to TNF-NFKB signaling pathway |
N00444 | TNF-p38 signaling pathway |
N00446 | TNF-JNK signaling pathway |
N00466 | EBV BPLF1 to TLR2/4-NFKB signaling pathway |
N00562 | HSV US3 to TLR2/4-NFKB signaling pathway |
N00563 | TLR3-NFKB signaling pathway |
N00692 | MV P to TLR2/4-NFKB signaling pathway |
N00859 | Yersinia YopP/J to TLR2/4-NFKB signaling pathway |
N00926 | Escherichia Tir to TLR2/4-MAPK signaling pathway |
N01566 | TLR5-NFKB signaling pathway |
N01797 | EDA-EDAR signaling pathway |
|
Disease |
H02226 | Cardiospondylocarpofacial syndrome |
H02227 | Frontometaphyseal dysplasia |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04310 Wnt signaling pathway
6885 (MAP3K7)
04064 NF-kappa B signaling pathway
6885 (MAP3K7)
04668 TNF signaling pathway
6885 (MAP3K7)
04152 AMPK signaling pathway
6885 (MAP3K7)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
6885 (MAP3K7)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
6885 (MAP3K7)
04620 Toll-like receptor signaling pathway
6885 (MAP3K7)
04660 T cell receptor signaling pathway
6885 (MAP3K7)
04657 IL-17 signaling pathway
6885 (MAP3K7)
09158 Development and regeneration
04380 Osteoclast differentiation
6885 (MAP3K7)
09160 Human Diseases
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
6885 (MAP3K7)
05161 Hepatitis B
6885 (MAP3K7)
05171 Coronavirus disease - COVID-19
6885 (MAP3K7)
05162 Measles
6885 (MAP3K7)
05169 Epstein-Barr virus infection
6885 (MAP3K7)
09171 Infectious disease: bacterial
05130 Pathogenic Escherichia coli infection
6885 (MAP3K7)
05131 Shigellosis
6885 (MAP3K7)
05135 Yersinia infection
6885 (MAP3K7)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
6885 (MAP3K7)
05140 Leishmaniasis
6885 (MAP3K7)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
6885 (MAP3K7)
05418 Fluid shear stress and atherosclerosis
6885 (MAP3K7)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
6885 (MAP3K7)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:hsa01001]
6885 (MAP3K7)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.25 mitogen-activated protein kinase kinase kinase
6885 (MAP3K7)
Protein kinases [BR:hsa01001]
Serine/threonine kinases: TKL group
MLK family
6885 (MAP3K7)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
6:complement(90513579..90587072)
|
AA seq |
606 aa
MSTASAASSSSSSSAGEMIEAPSQVLNFEEIDYKEIEVEEVVGRGAFGVVCKAKWRAKDV
AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAE
PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC
DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM
WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY
PCQYSDEGQSNSATSTGSFMDIASTNTSNKSDTNMEQVPATNDTIKRLESKLLKNQAKQQ
SESGRLSLGASRGSSVESLPPTSEGKRMSADMSEIEARIAATTAYSKPKRGHRKTASFGN
ILDVPEIVISGNGQPRRRSIQDLTVTGTEPGQVSSRSSSPSVRMITTSGPTSEKPTRSHP
WTPDDSTDTNGSDNSIPMAYLTLDHQLQPLAPCPNSKESMAVFEQHCKMAQEYMKVQTEI
ALLLQRKQELVAELDQDEKDQQNTSRLVQEHKKLLDENKSLSTYYQQCKKQLEVIRSQQQ
KRQGTS |
NT seq |
1821 nt +upstreamnt +downstreamnt
atgtctacagcctctgccgcctcctcctcctcctcgtcttcggccggtgagatgatcgaa
gccccttcccaggtcctcaactttgaagagatcgactacaaggagatcgaggtggaagag
gttgttggaagaggagcctttggagttgtttgcaaagctaagtggagagcaaaagatgtt
gctattaaacaaatagaaagtgaatctgagaggaaagcgtttattgtagagcttcggcag
ttatcccgtgtgaaccatcctaatattgtaaagctttatggagcctgcttgaatccagtg
tgtcttgtgatggaatatgctgaagggggctctttatataatgtgctgcatggtgctgaa
ccattgccatattatactgctgcccacgcaatgagttggtgtttacagtgttcccaagga
gtggcttatcttcacagcatgcaacccaaagcgctaattcacagggacctgaaaccacca
aacttactgctggttgcaggggggacagttctaaaaatttgtgattttggtacagcctgt
gacattcagacacacatgaccaataacaaggggagtgctgcttggatggcacctgaagtt
tttgaaggtagtaattacagtgaaaaatgtgacgtcttcagctggggtattattctttgg
gaagtgataacgcgtcggaaaccctttgatgagattggtggcccagctttccgaatcatg
tgggctgttcataatggtactcgaccaccactgataaaaaatttacctaagcccattgag
agcctgatgactcgttgttggtctaaagatccttcccagcgcccttcaatggaggaaatt
gtgaaaataatgactcacttgatgcggtactttccaggagcagatgagccattacagtat
ccttgtcagtattcagatgaaggacagagcaactctgccaccagtacaggctcattcatg
gacattgcttctacaaatacgagtaacaaaagtgacactaatatggagcaagttcctgcc
acaaatgatactattaagcgcttagaatcaaaattgttgaaaaatcaggcaaagcaacag
agtgaatctggacgtttaagcttgggagcctcccgtgggagcagtgtggagagcttgccc
ccaacctctgagggcaagaggatgagtgctgacatgtctgaaatagaagctaggatcgcc
gcaaccacagcctattccaagcctaaacggggccaccgtaaaactgcttcatttggcaac
attctggatgtccctgagatcgtcatatcaggcaacggacagccaagacgtagatccatc
caagacttgactgtaactggaacagaacctggtcaggtgagcagtaggtcatccagtccc
agtgtcagaatgattactacctcaggaccaacctcagaaaagccaactcgaagtcatcca
tggacccctgatgattccacagataccaatggatcagataactccatcccaatggcttat
cttacactggatcaccaactacagcctctagcaccgtgcccaaactccaaagaatctatg
gcagtgtttgaacagcattgtaaaatggcacaagaatatatgaaagttcaaacagaaatt
gcattgttattacagagaaagcaagaactagttgcagaactggaccaggatgaaaaggac
cagcaaaatacatctcgcctggtacaggaacataaaaagcttttagatgaaaacaaaagc
ctttctacttactaccagcaatgcaaaaaacaactagaggtcatcagaagtcagcagcag
aaacgacaaggcacttcatga |